Systemic and inhaled fluoroquinolones: risk of heart valve regurgitation/incompetence

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Active substance
  • Delafloxacin
  • levofloxacin
Regulatory outcome
Variation
DHPC type
Safety signal
Human ATC code
  • J01MA23
  • J01MA12
Dissemination date
29/10/2020
Related medicines

How useful was this page?

Add your rating